Options
Mobiliųjų programų poveikis, pagrįstas interaktyvia parama, antrojo tipo cukriniam diabetui: sisteminis atsitiktinės atrankos kontrolinis tyrimas
Saffari, Yasmine |
Recenzentas / Reviewer | |
Komisijos pirmininkas / Committee Chairman | |
Komisijos narys / Committee Member | |
Komisijos narys / Committee Member | |
Komisijos narys / Committee Member |
Title: The effect of mobile application based interactive support on type 2 diabetes mellitus: systematic review of randomized controlled trials. Objectives: The management of DMT2 has evolved substantially throughout history, however, as the increasing prevalence of type 2 diabetes mellitus has put pressure on health systems to appropriately manage these patients, multiple solutions are being discussed. For the past decade, mHealth has expanded rapidly as a subdivision of digital health to complement the healthcare management gaps of DMT2. This systematic review aims to analyze the effect of mobile apps, being a branch of mHealth, on glycemic hemoglobin of type 2 diabetes mellitus patients, suggesting its long-term effects. The primary objective of this systematic review was to analyze the effect of mobile apps on glycemic control of DMT2. To get a broader understanding the review considered the different aspects of disease management and prevention of its complications. Material and method: Electronic literature search was conducted in PubMed. The search strategy identified 147 records on the 5th of February 2022. Selection by the inclusion and exclusion criteria was followed and 83 articles remained for reviewing. The included articles were analyzed for risk of bias and relevant data was extracted using special forms. The data synthesis was quantitative and qualitative. Only randomized controlled trials were included in the study. Results: A total of 19 articles were included in the review. All included studies were RCTs that assessed the effectiveness of mHealth based self-management on long term management of diabetes mellitus type 2. 10 of 19 articles showed statistically significant decrease in HbA1c. Additionally 4/4 studies showed improved medication adherence, 3/6 reported lowered BMI and hip/waist circumference, 4/5 with improved postprandial glucose levels, 7/8 with lowered BP and serum lipid levels, 1/1 reported relieved anxiety symptoms and 5/5 studies reported improved self-efficacy in disease management. Conclusion: High certainty of evidence suggests that m-Health have a positive impact on glycated hemoglobin reduction in patients with type 2 diabetes mellitus. Additionally the systematic review found that m-Health improved secondary outcomes: medication adherence, blood lipids, blood pressure, postprandial glucose, anxiety and self-efficacy in disease management, as compared with control groups.
Mobiliųjų programų poveikis, pagrįstas interaktyvia parama, antrojo tipo cukriniam diabetui: sisteminis atsitiktinės atrankos kontrolinis tyrimas